Tagged Articles

litigation 958 articles

Man blames AndroGel for his heart attack

androgel-pump

Attorneys for a man suing AbbVie Inc., maker of AndroGel, told an Illinois federal jury that the drug company never tested its testosterone replacement therapy to rule out if it could cause heart problems, Law360 reported. Otherwise plaintiff Jeffrey Konrad would never have taken the drug, they said. Konrad’s case is the second bellwether trial in a multidistrict litigation (MDL) taking aim at testosterone manufacturers. AbbVie, as the maker of the top selling AndroGel, is the first drug maker to sit in the hot seat. The first trial against AbbVie ended in a $150 million in punitive damages for the ... Read More

Galena to pay $7.5M for illegally pushing potent opioid

opioid, oxycodone - Shutterstock

Galena Biopharma Inc., was ordered to pay more than $7.55 million to resolve allegations that it paid kickbacks to doctors to prescribe its potent fentanyl-based drug Abstral, the Department of Justice (DOJ) announced. Abstral is a powerful opioid that is only approved for breakthrough pain in cancer patients 18 years of age and older who are already tolerant to opioid therapy for their underlying persistent cancer pain. It is contraindicated for patients who are not already tolerant to opioids because life-threatening respiratory depression and death can result at any dose in patients not on a chronic regimen of opioids. For this ... Read More

Whistleblower Helps U.S. Recover $4M From NY Hospital Operator

Pills - Stethoscope on Money

The corporate owner-operator of two Queens, New York, hospitals has agreed to pay $4 million to settle a whistleblower lawsuit alleging it unlawfully billed Medicare for services forged from unlawful financial relationships with referring doctors. According to the whistleblower lawsuit, MediSys Health Network, Inc., which owns and operates Flushing Hospital Medical Center and Jamaica Hospital Medical Center, violated the False Claims Act by failing to comply with the requirements of the Stark Law, which restricts the financial relationships that hospitals may have with the physicians who refer patients to them. “When hospital operators provide financial incentives to doctors for patient referrals, ... Read More

Study compares Zytiga and Taxotere for high-risk prostate cancer treatment

alopecia, woman, hair loss, Taxotere - Shutterstock

A recent study compared Zytiga (abiraterone acetate) plus prednisolone (AAP) versus Taxotere (docetaxel). The study analysed data gathered in STAMPEDE, a Phase 2/3 trial, which has prospectively studied more than 9,000 patients and includes six different approaches to treating high-risk or metastatic hormone sensitive prostate cancer. Two of the treatments included in STAMPEDE were AAP and Taxotere added to the standard hormone deprivation therapy, with 377 patients randomly assigned into the AAP treatment group and 189 into the Taxotere group. Both drugs had previously shown promise in improving survival in patients with high-risk prostate cancer when compared to the standard treatment ... Read More

Lilly discontinues Axiron testosterone solutions

Axiron

Eli Lilly & Co. is discontinuing two of its Axiron testosterone replacement therapy solutions and its authorized generic testosterone solution because there are multiple manufacturers that are currently selling the products, according to MPR. The discontinued products include Axiron 30mg /1.5mL with the NDC 0002-1975-90, Axiron 30mg/1.5mL with the NDC 0002-1975-61, and generic testosterone 30mg/1.5mL with the NDC 66993-963-89. Axiron solution is an androgen used to treat adult men with congenital or acquired primary hypogonadiasm or hypogonadotropic hypogonadism. It is supplied as a 90mL pump containing 60 metered pump or twist actuations with an applicator. Eli Lilly claims that the ... Read More

Jury awards $57.1 Million for Defective Pelvic Mesh Implant

TVM woman

Johnson & Johnson was slapped with a $57.1 million verdict, awarded to a woman who alleges her pelvic mesh implant was defective, scarred her urethra, and caused her incontinence. Ella Ebaugh, the recipient of two Ethicon pelvic mesh devices, claims the mesh was defective, ultimately leaving her with a “mutilated” urethra and severe incontinence. The award included an eye-popping $50 million in punitive damages, Law360 reports. “Hopefully they recognize that their conduct was reckless,” Ebaugh’s attorney told Law360. “I hope this sends a clear message that they did something wrong with these products and that they really think, going forward, about what they ... Read More

Arkansas Woman Alleges Physiomesh Severely Injured Her

physiomesh

An Arkansas woman who alleges Physiomesh is responsible for her severe injuries has filed a lawsuit against the manufacturer in a case that is now part of a multidistrict litigation (MDL) in the Northern District of Georgia. Jennifer Stone was implanted with a Physiomesh hernia repair mesh on June 29, 2011, for the repair of a ventral hernia. The mesh device, made polypropylene with four additional layers, is designed to bridge the gap of a hernia with the intention of allowing it to heal. Later, Stone says she had no choice but to undergo invasive medical treatments from the complications ... Read More

AndroGel marketing materials cannot be barred from next trial

androgel-pump

AbbVie Inc., failed to convince an Illinois federal judge to block jurors from seeing its marketing materials for its testosterone replacement therapy AndroGel in the next bellwether trial in a mulstidistrict litigation (MDL), according to Law360. The drug company’s aggressive marketing practices were the damning evidence in the first testosterone side effects trial to reach verdict in the MDL, costing AbbVie $150 million in punitive damages to a couple who sued the company over cardiovascular risks. U.S. District Judge Matthew F. Kennelly denied AbbVie’s motion for reconsideration on his ruling and punished the company by docking 30 minutes of trial ... Read More

Verdict reached in first testosterone state case

androgel-pump

Pharmaceutical company AbbVie Inc. scored a win in Illinois state court over claims that the company’s testosterone replacement therapy AndroGel caused a man’s heart attack, according to Law360. The news come just weeks after an Oregon couple was awarded $150 million in a similar case involving AndroGel in an Illinois federal court. James Couch sued AbbVie alleging the drug maker failed to warn him or his doctor that using AndroGel could cause cardiovascular risks including life-threatening heart attacks, strokes and blood clots. Couch’s lawsuit is one of about 150 in Cook County, Illinois state court involving testosterone side effects. Couch claimed strict ... Read More

Honda Reaches $605 Million Takata Airbag Settlement

Honda Takata airbags

Honda Motor Co. agreed Friday to pay $605 million to settle its part of multidistrict litigation (MDL) over defective Takata airbags, opening the door to compensation for customers who have incurred out-of-pocket expenses and speeding up replacement of the faulty airbags in remaining vehicles. The preliminary deal includes an outreach program that is designed to help owners of about 16.5 million of Honda and Acura vehicles get their Takata airbags repaired more quickly, including payments up to $500 per owner, free rental cars, and providing reimbursements for lost wages, childcare, and other expenses vehicle owners rack up to get their ... Read More